Fritz P - Search Results

1

Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.

Schroth W, Winter S, Büttner F, Goletz S, Faißt S, Brinkmann F, Saladores P, Heidemann E, Ott G, Gerteis A, Alscher MD, Dippon J, Schwab M, Brauch H, Fritz P. Schroth W, et al. Among authors: fritz p. Breast Cancer Res Treat. 2016 Jan;155(1):85-97. doi: 10.1007/s10549-015-3651-5. Epub 2015 Dec 9. Breast Cancer Res Treat. 2016. PMID: 26650824

2

The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer.

Amaral S, Schroth W, Kugler S, Fritz P, Simon W, Brauch H. Amaral S, et al. Among authors: fritz p. Breast Cancer Res Treat. 2009 Nov;118(2):323-31. doi: 10.1007/s10549-008-0241-9. Epub 2008 Nov 15. Breast Cancer Res Treat. 2009. PMID: 19011961

3

A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.

Rokavec M, Schroth W, Amaral SM, Fritz P, Antoniadou L, Glavac D, Simon W, Schwab M, Eichelbaum M, Brauch H. Rokavec M, et al. Among authors: fritz p. Cancer Res. 2008 Dec 1;68(23):9799-808. doi: 10.1158/0008-5472.CAN-08-0247. Cancer Res. 2008. PMID: 19047159

4

Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.

Hoppe R, Achinger-Kawecka J, Winter S, Fritz P, Lo WY, Schroth W, Brauch H. Hoppe R, et al. Among authors: fritz p. Eur J Cancer. 2013 Nov;49(17):3598-608. doi: 10.1016/j.ejca.2013.07.145. Epub 2013 Aug 19. Eur J Cancer. 2013. PMID: 23968733

5

Tubular breast cancer. A retrospective study.

Fritz P, Bendrat K, Sonnenberg M, Trautmann C, Ott G, Heidemann E, Brinkmann F, Faisst S, Gerteis A, Brauch H, Schwab M, Lindner C, Friedrichs K, Alscher MD, Dippon J, Niendorf A. Fritz P, et al. Anticancer Res. 2014 Jul;34(7):3647-56. Anticancer Res. 2014. PMID: 24982382

6

Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem.

Fritz P, Dippon J, Müller S, Goletz S, Trautmann C, Pappas X, Ott G, Brauch H, Schwab M, Winter S, Mürdter T, Brinkmann F, Faisst S, Rössle S, Gerteis A, Friedel G. Fritz P, et al. Anticancer Res. 2018 Mar;38(3):1585-1593. doi: 10.21873/anticanres.12388. Anticancer Res. 2018. PMID: 29491089

7

Clinical impacts of histological subtyping primary breast cancer.

Fritz P, Klenk S, Goletz S, Gerteis A, Simon W, Brinkmann F, Heidemann E, Lütttgen E, Ott G, Alscher MD, Schwab M, Dippon J. Fritz P, et al. Anticancer Res. 2010 Dec;30(12):5137-44. Anticancer Res. 2010. PMID: 21187502

8

Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.

Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H. Abraham BK, et al. Among authors: fritz p. Clin Cancer Res. 2005 Feb 1;11(3):1154-9. Clin Cancer Res. 2005. PMID: 15709183

9

c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.

Fritz P, Cabrera CM, Dippon J, Gerteis A, Simon W, Aulitzky WE, van der Kuip H. Fritz P, et al. Breast Cancer Res. 2005;7(3):R374-84. doi: 10.1186/bcr1012. Epub 2005 Mar 21. Breast Cancer Res. 2005. PMID: 15987433 Free PMC article.

10

Smad4-expression is decreased in breast cancer tissues: a retrospective study.

Stuelten CH, Buck MB, Dippon J, Roberts AB, Fritz P, Knabbe C. Stuelten CH, et al. Among authors: fritz p. BMC Cancer. 2006 Jan 26;6:25. doi: 10.1186/1471-2407-6-25. BMC Cancer. 2006. PMID: 16438724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

396 results

Search Page